APOB and familial hyperaldosteronism: Cayo et al. (70) developed a screen using iPSC-derived hepatocytes from a patient with FH to screen a library of 2,320 small molecules that reduced the levels of apoB, which is the central protein component of (v)LDL, in the media of cultured FH iPSC-derived hepatocytes.